Bayesian adaptive trial designs for precision medicine

Dr Lee speaks with ecancer at WIN 2017 about changing attitudes and designs of trial design to a Bayesian framework, which integrates serial data collection into the assessment of patient response.

He notes 20% of trials conducted at M.D. Anderson incorporate some elements of Bayesian design, including the I-SPY 2 trial, discussed at AACR 2016.